230 related articles for article (PubMed ID: 33931094)
1. Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE.
Niewold TB; Meves A; Lehman JS; Popovic-Silwerfeldt K; Häyry A; Söderlund-Matell T; Charlesworth CM; Madden B; Lundberg IE; Wahren-Herlenius M; Svenungsson E; Oke V
Arthritis Res Ther; 2021 Apr; 23(1):132. PubMed ID: 33931094
[TBL] [Abstract][Full Text] [Related]
2. IL18-containing 5-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions.
Tsoi LC; Gharaee-Kermani M; Berthier CC; Nault T; Hile GA; Estadt SN; Patrick MT; Wasikowski R; Billi AC; Lowe L; Reed TJ; Gudjonsson JE; Kahlenberg JM
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32644977
[TBL] [Abstract][Full Text] [Related]
3. Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study.
Monfort JB; Chasset F; Barbaud A; Frances C; Senet P
Lupus; 2021 Jul; 30(8):1207-1213. PubMed ID: 33853419
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
5. IL-1β and IL-17 in cutaneous lupus erythematous skin biopsies: could immunohistochemicals indicate a tendency towards systemic involvement?
Lovato BH; Fogagnolo L; Souza EM; Silva LJBD; Velho PENF; Cintra ML; Teixeira F
An Bras Dermatol; 2024; 99(1):66-71. PubMed ID: 37783618
[TBL] [Abstract][Full Text] [Related]
6. Increased Epidermal Nerve Growth Factor without Small-Fiber Neuropathy in Dermatomyositis.
Wong LS; Lee CH; Yen YT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012289
[TBL] [Abstract][Full Text] [Related]
7. The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP).
Robinson ES; Payne AS; Pappas-Taffer L; Feng R; Werth VP
J Am Acad Dermatol; 2016 Jul; 75(1):42-8. PubMed ID: 27317514
[TBL] [Abstract][Full Text] [Related]
8. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
10. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus.
Barkauskaite V; Ek M; Popovic K; Harris HE; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(10):794-802. PubMed ID: 17895302
[TBL] [Abstract][Full Text] [Related]
11. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
[TBL] [Abstract][Full Text] [Related]
13. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
Robinson ES; Werth VP
Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
[TBL] [Abstract][Full Text] [Related]
14. Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.
Chang LM; Maheshwari P; Werth S; Schaffer L; Head SR; Kovarik C; Werth VP
J Histochem Cytochem; 2011 Mar; 59(3):336-45. PubMed ID: 21378287
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.
Popovic K; Ek M; Espinosa A; Padyukov L; Harris HE; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2005 Nov; 52(11):3639-45. PubMed ID: 16255056
[TBL] [Abstract][Full Text] [Related]
16. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
17. The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.
Nakamura K; Jinnin M; Kudo H; Inoue K; Nakayama W; Honda N; Kajihara I; Masuguchi S; Fukushima S; Ihn H
Br J Dermatol; 2016 May; 174(5):1030-41. PubMed ID: 26713607
[TBL] [Abstract][Full Text] [Related]
18. Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.
Chang YC; Werth VP
Curr Dermatol Rep; 2013 Mar; 2(1):48-57. PubMed ID: 33585073
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
Yazdani MR; Aflaki E; Gholijani N
Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis.
Pablos JL; Santiago B; Galindo M; Carreira PE; Ballestin C; Gomez-Reino JJ
J Pathol; 1999 May; 188(1):63-8. PubMed ID: 10398142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
